Taro Pharmaceuticals Inc.
Taro Pharmaceuticals Inc., commonly referred to as Taro, is a prominent player in the pharmaceutical industry, headquartered in Ontario, Canada. Founded in 2000, Taro has established itself as a leader in the development, manufacturing, and marketing of generic and specialty pharmaceuticals, primarily focusing on dermatology, pain management, and other therapeutic areas. With a robust portfolio of products, Taro is renowned for its commitment to quality and innovation, offering unique formulations that cater to diverse patient needs. The company has achieved significant milestones, including regulatory approvals and strategic partnerships that enhance its market position. Taro's dedication to research and development, combined with its operational presence in key regions, solidifies its reputation as a trusted provider in the global pharmaceutical landscape.
DitchCarbon Score
How does Taro Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Taro Pharmaceuticals Inc.'s score of 27 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Taro Pharmaceuticals Inc.'s reported carbon emissions
Taro Pharmaceuticals Inc., headquartered in California, currently does not have publicly available data on its carbon emissions, as there are no reported figures for emissions in kg CO2e. Additionally, the company has not outlined specific reduction targets or initiatives related to carbon emissions. In the context of the pharmaceutical industry, many companies are increasingly committing to sustainability and climate action, often setting science-based targets to reduce their carbon footprint across Scope 1, 2, and 3 emissions. However, without specific commitments or data from Taro Pharmaceuticals, it is unclear how they align with these industry standards. As the focus on climate responsibility grows, it will be important for Taro Pharmaceuticals to establish clear climate commitments and transparency regarding their emissions to meet stakeholder expectations and contribute to global sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Taro Pharmaceuticals Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
